Pages

▼
Friday, June 05, 2026

Pharmacy Copay Misuse: The Multi-Billion Dollar Issue Hiding In Plain Sight

›
Today’s guest post comes from Stephen Hom, Co-Founder, EVP & Chief Operating Officer of RIS Rx. Drawing on RIS Rx’s proprietary data an...
Tuesday, June 02, 2026

The 340B Contract Pharmacy Market in 2026: A Maturing Industry Dominated by Big Chains and PBMs

›
By Adam J. Fein, Ph.D. and Greis Kapexhiu It’s time for Drug Channels Institute’s latest exclusive analysis of the 340B contract pharmacy m...
Friday, May 29, 2026

Drugs, Discounts and Data: Crafting Sustainability in an Imperfect System

›
Today’s guest post comes from Angie Franks, Chief Executive Officer at Kalderos. As Angie explains, the industry still lacks the transparen...
Wednesday, May 27, 2026

Drug Channels News Roundup, May 2026: My $0.02 on Optum Rx’s Transparency, Must-Read 340B History, PBM Unbundling Update, PA Delays, and Vegas Fun

›
By Adam J. Fein, Ph.D. Summer unofficially kicked off last weekend. So fire up the grill and enjoy these noteworthy delicacies, seared to pe...
Wednesday, May 20, 2026

PBM Shakeout: How Vertical Integration Is Reshaping What’s Next (VIDEO)

›
Here at Drug Channels , we’ve been closely tracking the evolution of the pharmacy benefit management (PBM) industry for many years. The sho...
Friday, May 15, 2026

Protecting Gross-to-Net Performance Through Single-Channel Ecosystems

›
Today’s guest post comes from Peter Darch, SVP of Strategy and Operations at PHIL Inc. Peter explains that growing pressure on drug prici...
Wednesday, May 13, 2026

Drug Channels News Roundup, Mid-May 2026: Flawed Launch Price Math, Rising Pharmacy Closures, Hospital Pay Realities, 340B Hospitals vs. Grantees, and a Luxury Take on Specialty Pharmacy

›
By Bryce Platt, PharmD The onslaught of pharmacy-related news doesn’t end. It may even be increasing in volume due to AI. But don’t worr...
Tuesday, May 12, 2026

340B in 2026: Market Shifts, Policy Battles, and What They Mean for Stakeholders (NEW Live Video Webinar)

›
Join Dr. Adam J. Fein, president of Drug Channels Institute (DCI) and the editor of Drug Channels , for his latest exclusive video webinar: ...
Friday, May 08, 2026

The Hidden Costs of Over-Customizing Your Hub Technology Stack

›
Today’s guest post comes from George Moore, Chief Product and Technology Officer at CareMetx. George argues that customer relationship ma...
Tuesday, May 05, 2026

Specialty Pharmacy Accreditation: DCI’s Exclusive Analysis Reveals a Market at an Inflection Point

›
By Adam J. Fein, Ph.D. The Drug Channels Institute (DCI) team attended Asembia’s AXS26 Summit last week. Once again, the specialty pharmacy ...
Friday, May 01, 2026

Where Gross-to-net Pressure Actually Lives After Launch

›
Today’s guest post comes from Cindy Baksh, Chief Product Officer at ConnectiveRx. Cindy explains that many gross-to-net (GTN) exposures n...
Tuesday, April 28, 2026

Drug Channels News Roundup, April 2026: PBM Specialty Pharmacy Steering, MLR Profit Shifting, Hospitals’ Fake Prices, and a Peek Behind the Scenes at DCI

›
By Adam J. Fein, Ph.D. Spring has officially arrived at Drug Channels' worldwide headquarters in beautiful downtown Philadelphia. (Photo...